156 related articles for article (PubMed ID: 23740134)
21. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.
Matullo G; Palli D; Peluso M; Guarrera S; Carturan S; Celentano E; Krogh V; Munnia A; Tumino R; Polidoro S; Piazza A; Vineis P
Carcinogenesis; 2001 Sep; 22(9):1437-45. PubMed ID: 11532866
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.
Bewick MA; Conlon MS; Lafrenie RM
J Clin Oncol; 2006 Dec; 24(36):5645-51. PubMed ID: 17116943
[TBL] [Abstract][Full Text] [Related]
23. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of ovarian cancer death after chemotherapy.
Cheng CX; Xue M; Li K; Li WS
Asian Pac J Cancer Prev; 2012; 13(6):2541-5. PubMed ID: 22938418
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia.
Bănescu C; Trifa AP; Demian S; Benedek Lazar E; Dima D; Duicu C; Dobreanu M
Biomed Res Int; 2014; 2014():213790. PubMed ID: 24955348
[TBL] [Abstract][Full Text] [Related]
26. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; Selvaggi G; Gregori D; DeMarchi M; Scagliotti GV
Clin Cancer Res; 2007 May; 13(10):2876-81. PubMed ID: 17504986
[TBL] [Abstract][Full Text] [Related]
27. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
28. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.
Liu B; Wei J; Zou Z; Qian X; Nakamura T; Zhang W; Ding Y; Feng J; Yu L
Eur J Hum Genet; 2007 Oct; 15(10):1049-53. PubMed ID: 17593927
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study.
Kipikasová L; Wolaschka T; Bohus P; Baumohlová H; Bober J; Blazejová J; Mirossay L; Sarisský M; Mirossay A; Cizmáriková M; Potoceková D; Mojzis J
Pathol Oncol Res; 2008 Jun; 14(2):131-5. PubMed ID: 18415712
[TBL] [Abstract][Full Text] [Related]
31. Single nucleotide polymorphisms in DNA repair genes and the risk of laryngeal cancer: A meta-analysis.
Li F; Wang J; Chen M
Biomed Pharmacother; 2016 Mar; 78():92-100. PubMed ID: 26898429
[TBL] [Abstract][Full Text] [Related]
32. Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients.
Hussien YM; Gharib AF; Awad HA; Karam RA; Elsawy WH
Mol Biol Rep; 2012 Feb; 39(2):1895-901. PubMed ID: 21643959
[TBL] [Abstract][Full Text] [Related]
33. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
[TBL] [Abstract][Full Text] [Related]
34. DNA repair gene variants in endometrial carcinoma.
Cincin ZB; Iyibozkurt AC; Kuran SB; Cakmakoglu B
Med Oncol; 2012 Dec; 29(4):2949-54. PubMed ID: 22271435
[TBL] [Abstract][Full Text] [Related]
35. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
[TBL] [Abstract][Full Text] [Related]
36. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
37. The investigation of DNA repair polymorphisms with histopathological characteristics and hormone receptors in a group of Brazilian women with breast cancer.
Dufloth RM; Arruda A; Heinrich JK; Schmitt F; Zeferino LC
Genet Mol Res; 2008 Jul; 7(3):574-82. PubMed ID: 18752184
[TBL] [Abstract][Full Text] [Related]
38. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency.
Guven M; Guven GS; Oz E; Ozaydin A; Batar B; Ulutin T; Hacihanefioglu S; Domanic N
Heart Vessels; 2007 Nov; 22(6):355-60. PubMed ID: 18043991
[TBL] [Abstract][Full Text] [Related]
39. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Liu L; Yuan P; Wu C; Zhang X; Wang F; Guo H; Zhong R; Xu Y; Wu J; Yu D; Wu T; Zhang X; Nie S; Miao X; Lin D
Lung Cancer; 2011 Jul; 73(1):110-5. PubMed ID: 21129812
[TBL] [Abstract][Full Text] [Related]
40. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
